Skip to content

Comparison of dexmedetomedine and lidocaine 2% in controlling analgesia and hemodynamic changes in cataract surgery with local anesthesia

Comparison of dexmedetomedine and lidocaine 2% in controlling analgesia and hemodynamic changes in cataract surgery with local anesthesia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210415050976N7
Enrollment
52
Registered
2021-08-28
Start date
2021-11-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Diabetes mellitus due to underlying condition with diabetic cataract

Interventions

Intervention 1: Intervention group 1: They will receive 3 cc of lidocaine 2% retrobularly. Intervention 2: Intervention group 2: 5 µg / kg dexmedetomedin + 3 cc lidocaine 2% will receive retrobulbar

Sponsors

Jahrom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having surgical indications Indication of local anesthesia

Exclusion criteria

Exclusion criteria: The patient refuses local anesthesia even after careful consultation and explanation of the risks of this procedure Uncontrolled Parkinson's patient Patient with severe medical condition to limit the appropriate position in cataract surgery Patient with a history of severe reactions Allergy or other side effects to lidocaine or dexmedetomidine

Design outcomes

Primary

MeasureTime frame
Vital Signs. Timepoint: After retrobulbar block, one and two hours after the onset of retrobulbar block. Method of measurement: monitoring.;The pain. Timepoint: One and two hours of retrobulbar block. Method of measurement: VAS criteria.

Secondary

MeasureTime frame
Intraocular pressure. Timepoint: Before and after retrobulbar block. Method of measurement: Tonometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Sahraei

Jahrom University of Medical Sciences

sahraeir1354@gmail.com+98 71 2536 5231

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026